Results 141 to 150 of about 3,493 (205)

PB1 mutations as key drivers of influenza A virus evolution. [PDF]

Front Microbiol
Fang C, Sun X, Feng Y, Song H, Wang S.
europepmc   +1 more source

Influenza Vaccination Among Children With Asthma: Challenges and Future Directions. [PDF]

Acad Pediatr
Geissler KH, Poronsky KE, Shieh MS, Lindenauer PK, Ash AS, Goff SL.   +5 more
europepmc   +1 more source

Live attenuated influenza vaccine with low proportions of defective interfering particles elicits robust immunogenicity and cross-protection. [PDF]

Nat Commun
Wu M, Wang P, Wang L, Li C, Sheng R, Dong H, Fu X, Zhou E, Zhang C, Lu T, Jin Z, Qin J, Miao Y, Yue L, Pan D, Li C, Liang C, Kiseleva I, Rudenko L, Jiang C, Chen F, Su W.   +21 more
europepmc   +1 more source

Influenza vaccination in children with underlying conditions: affirming effectiveness and confronting gaps. [PDF]

Transl Pediatr
Geissler KH, Peacock-Chambers E.
europepmc   +1 more source

ACIP’s 2019 immunization schedule: New layout, LAIV added, other key changes [PDF]

Pharmacy Today, 2019
openaire   +1 more source

Respiratory mucosal vaccines for emerging viruses: promise and challenges. [PDF]

J Virol
Beeton K, Case JB.
europepmc   +1 more source

Intranasal NS1-truncated live attenuated canine influenza vaccine confers superior protection compared to inactivated vaccine in beagles. [PDF]

Vet Res
Hwang J, Yoon SW, Ga E, Choi J, Moon S, Bae E, Yun H, Yu D, Kim HK, Kang JA, Yeom M, Lim JW, Jeong DG, Xie X, Song D, Na W.   +15 more
europepmc   +1 more source

Immune history confers antibody- and T cell-dependent cross-protection against highly pathogenic avian influenza H5N1 viruses. [PDF]

J Virol
Brigleb PH, Sharp B, Lazure L, Livingston B, Patrick S, Meliopoulos V, Kirkpatrick Roubidoux E, Van de Velde L-A, Tan S, Morris DR, Ripperger T, Rowland L, Thompson AC, Kleinhenz K, Balaraman V, Dimitrov K, Thomas PG, Schultz-Cherry S.   +17 more
europepmc   +1 more source

Influenza B Vaccines: Current Landscape and Novel Development Strategies. [PDF]

Vaccines (Basel)
Kotlyarov RY, Ravin NV, Mardanova ES.
europepmc   +1 more source

Development of a broad-spectrum nasal live attenuated influenza vaccine based on mosaic antigen design against influenza B viruses. [PDF]

Emerg Microbes Infect
Han X, Ma R, Ma X, Chen H, Zhao T, Liu X, Zhu L, Yuan L, Shi Y, Zhang Y, Yang Z, Chen Q, Lu J, Chen C, Pang W, Bai T, Zhu W, Shu Y.   +17 more
europepmc   +1 more source